Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|March 16, 2021
Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosisSamuel J Modlin, Tyler Marbach, Jim Werngren, et al.
NAR Molecular Medicine|November 19, 2025
Intercellular mosaic methylation in fast-growing Mycobacterium tuberculosis clinical isolatesMaryam Ahmadi Jeshvaghane, Samuel J Modlin, Derek Conkle-Gutierrez, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 12, 2023
Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular DiagnosticsSamuel J Modlin, Mikael Mansjö, Jim Werngren, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 11, 2024
Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugsDerek Conkle-Gutierrez, Bria M Gorman, Nachiket Thosar, et al.
Microbial Genomics|January 27, 2021
Exact mapping of Illumina blind spots in the Mycobacterium tuberculosis genome reveals platform-wide and workflow-specific biasesSamuel J Modlin, Cassidy Robinhold, Christopher Morrissey, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2022
Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association StudyDerek Conkle-Gutierrez, Calvin Kim, Sarah M Ramirez-Busby, et al.
Pageof 2